CAD 1.31
(-2.24%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 4.08 Billion USD | -11.75% |
2022 | 4.62 Billion USD | 17.96% |
2021 | 3.92 Billion USD | 30.15% |
2020 | 3.01 Billion USD | 215.36% |
2019 | 955.6 Million CAD | 22.78% |
2018 | 778.28 Million CAD | 309.73% |
2017 | 189.94 Million CAD | 296275.04% |
2016 | 64.09 Thousand CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 4.17 Billion USD | -0.03% |
2024 Q2 | 3.08 Billion USD | 0.08% |
2023 FY | 4.08 Billion USD | -11.75% |
2023 Q4 | 4.08 Billion USD | -6.4% |
2023 Q3 | 4.36 Billion USD | -0.21% |
2023 Q2 | 4.37 Billion USD | -3.96% |
2023 Q1 | 4.55 Billion USD | -1.14% |
2022 Q2 | 4.53 Billion CAD | 2.29% |
2022 Q1 | 4.43 Billion CAD | 7.66% |
2022 Q3 | 4.87 Billion CAD | 7.38% |
2022 Q4 | 4.6 Billion USD | -5.52% |
2021 Q4 | 4.12 Billion CAD | 2.46% |
2021 Q3 | 4.02 Billion CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aurora Cannabis Inc. | 838.67 Million CAD | -386.858% |
Avicanna Inc. | 21.97 Million CAD | -18484.157% |
Avant Brands Inc. | 82.55 Million CAD | -4846.149% |
Cardiol Therapeutics Inc. | 36.7 Million CAD | -11025.582% |
Crescita Therapeutics Inc. | 24.59 Million CAD | -16499.5% |
Knight Therapeutics Inc. | 945.49 Million CAD | -331.854% |
MediPharm Labs Corp. | 63.93 Million CAD | -6286.201% |
OrganiGram Holdings Inc. | 298.45 Million CAD | -1268.094% |
Canopy Growth Corporation | 1.3 Billion CAD | -214.008% |
Willow Biosciences Inc. | 6.67 Million CAD | -61089.047% |
Auxly Cannabis Group Inc. | 261.9 Million CAD | -1459.024% |